Thromboreductive Strategies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
[[Category:Cardiology]] | ==References== | ||
{{reflist|2}} | |||
[[Category:Cardiology]] | |||
[[Category:Hematology]] | |||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:13, 1 November 2011
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Thromboreductive Strategies On the Web |
|
Directions to Hospitals Treating Thromboreductive Strategies |
|
Risk calculators and risk factors for Thromboreductive Strategies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Synonyms and keywords: PE
Overview
Presence of a residual thrombus doubles the risk of recurrent venous thromboembolism and Post-thrombotic syndrome[1].
References
- ↑ Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P; et al. (2002). "Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism". Ann Intern Med. 137 (12): 955–60. PMID 12484710.